Pyros Drug Patent Portfolio
Pyros owns 1 orange book drug protected by 2 US patents Given below is the list of Pyros's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12290499 | Vigabatrin liquid pharmaceutical composition | 17 Oct, 2042 | Active |
| US12016857 | Stable liquid vigabatrin pharmaceutical composition for oral dosage | 16 Aug, 2039 | Active |
Latest Legal Activities on Pyros's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Pyros.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 06 May, 2025 | US12290499 |
| Email Notification | 06 May, 2025 | US12290499 |
| Recordation of Patent Grant Mailed | 06 May, 2025 | US12290499 |
| Recordation of Patent eGrant | 06 May, 2025 | US12290499 |
| Patent Issue Date Used in PTA Calculation | 06 May, 2025 | US12290499 |
| Mail Patent eGrant Notification | 06 May, 2025 | US12290499 |
| Email Notification | 17 Apr, 2025 | US12290499 |
| Issue Notification Mailed | 16 Apr, 2025 | US12290499 |
| Application Is Considered Ready for Issue | 07 Apr, 2025 | US12290499 |
| Dispatch to FDC | 07 Apr, 2025 | US12290499 |
| Issue Fee Payment Received | 04 Apr, 2025 | US12290499 |
| Issue Fee Payment Verified | 04 Apr, 2025 | US12290499 |
| Response to Reasons for Allowance | 04 Apr, 2025 | US12290499 |
| Mail Notice of Allowance | 25 Mar, 2025 | US12290499 |
| Notice of Allowance Data Verification Completed | 20 Mar, 2025 | US12290499 |
Pyros's Family Patents
Pyros Drug List
Given below is the complete list of Pyros's drugs and the patents protecting them.
1. Vigafyde
Vigafyde is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12290499 | Vigabatrin liquid pharmaceutical composition |
17 Oct, 2042
(16 years from now)
| Active |
| US12016857 | Stable liquid vigabatrin pharmaceutical composition for oral dosage |
16 Aug, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vigafyde's drug page